TB Modeling and Analysis Consortium

Location

Baltimore, Maryland, US

Dates

01/01/2013 - 12/01/2015

PI

David Dowdy, MD, PhD, ScM

The TB MAC brings TB modelers together from a wide range of institutions to answer questions of global policy relevance.  I sit on the 7-member steering committee, and we have contributed modeling results to a recent comparative modeling exercise aiming to understand our capacity to reach the post-2015 TB targets.

Projects

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

A smoking cessation trial in HIV/AIDS...

A tobacco prevalence survey and smoking cessation trial among HIV infected patients in South Africa.

Read More

Statins as adjunctive host-directed therapy...

This study will investigate the role of statins in combination with the first-line regimen for TB in the mouse model. In...

Read More

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More

Evaluating an automated system for...

We are evaluating the accuracy and cost-effectiveness of TBDx, an automated digital microscopy system, as a screening test to...

Read More